Abstract
Epithelial ovarian cancer is a leading cause of death in gynecological cancers. While several systematic studies have revealed the mutation landscape of serous epithelial ovarian cancer, other non-serous subtypes of the disease have not been explored as extensively. Here we conduct exome sequencing of nine non-serous epithelial ovarian tumors (six endometrioid and three mucinous) and their corresponding normal DNA as well as a tumor-only granulosa cell sample. We integrated the exome data with targeted gene sequencing for 1,321 genes selected for their involvement in cancer from additional 28 non-serous ovarian tumors and compared our results to TCGA ovarian serous cystadenocarcinoma and uterine corpus endometrial carcinomas. Prevalence of TP53 mutations in non-serous was much lower than in serous epithelial OC, whereas the prevalence of PIK3CA, PIK3R1, PTEN, CTNNB1, ARID1A, and KRAS was higher. We confirmed the high prevalence of FOXL2 and KRAS mutations in granulosa cell tumors and in mucinous tumors, respectively. We also identified POLE proofreading domain mutations in three endometrioid ovarian tumors. These results highlight mutational differences between serous and non-serous ovarian cancers, and further distinguish different non-serous subtypes.
Highlights
Epithelial Ovarian Cancer (EOC) is a heterogeneous disease with five major histologic types[1, 2]: high-grade serous carcinoma, which accounts for the approximately 70% of all EOC cases, and clear cell (10%), endometrioid (10%), mucinous (3%), and low-grade serous carcinomas (
Type I tumors are slow growing and encompass low-grade serous, low-grade endometrioid, mucinous and clear cell carcinomas characterized by mutations in KRAS, BRAF, and PIK3CA and by the absence of TP53 mutations[6]
We report mutational and copy number profiles indicating that non-serous ovarian cancer is genomically distinct from serous EOC and displays similarities to non-serous endometrial uterine cancer
Summary
Epithelial Ovarian Cancer (EOC) is a heterogeneous disease with five major histologic types[1, 2]: high-grade serous carcinoma, which accounts for the approximately 70% of all EOC cases, and clear cell (10%), endometrioid (10%), mucinous (3%), and low-grade serous carcinomas (
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
